Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number.
Podhorecka, Monika
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number. [electronic resource] - Oncotarget May 2017 - 34661-34669 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.16148 doi
Adenine--analogs & derivatives
Adult
Aged
Cell Proliferation--drug effects
Cytokines--metabolism
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Male
Middle Aged
Piperidines
Prognosis
Pyrazoles--administration & dosage
Pyrimidines--administration & dosage
Signal Transduction--drug effects
T-Lymphocyte Subsets--drug effects
T-Lymphocytes, Regulatory--drug effects
Treatment Outcome
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number. [electronic resource] - Oncotarget May 2017 - 34661-34669 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.16148 doi
Adenine--analogs & derivatives
Adult
Aged
Cell Proliferation--drug effects
Cytokines--metabolism
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Male
Middle Aged
Piperidines
Prognosis
Pyrazoles--administration & dosage
Pyrimidines--administration & dosage
Signal Transduction--drug effects
T-Lymphocyte Subsets--drug effects
T-Lymphocytes, Regulatory--drug effects
Treatment Outcome